Geng Meiyu (front row, left) and her research team at the Chinese Academy of Sciences have successfully developed the first world’s medication for Alzheimer’s Disease in nearly 20 years. Photo: Xinhua

China approves Oligomannate, world’s first new Alzheimer’s drug in 20 years and it is based on seaweed

  • Clinical trial shows effectiveness in treating mild to moderate forms of the disease, and it may even improve cognitive function
  • Researchers noticed elderly people who regularly eat seaweed are less likely to develop the condition
Topic |   China science

TOP PICKS

Geng Meiyu (front row, left) and her research team at the Chinese Academy of Sciences have successfully developed the first world’s medication for Alzheimer’s Disease in nearly 20 years. Photo: Xinhua
READ FULL ARTICLE
Stephen Chen

Stephen Chen

Stephen Chen investigates major research projects in China, a new power house of scientific and technological innovation. He has worked for the Post since 2006. He is an alumnus of Shantou University, the Hong Kong University of Science and Technology, and the Semester at Sea programme which he attended with a full scholarship from the Seawise Foundation.